Greening, D. W., Lee, S. T., Ji, H., Simpson, R. J., Rigopoulos, A., Murone, C., . . . Scott, A. M. (2015). Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways. Oncotarget.
Citação norma ChicagoGreening, David W., et al. "Molecular Profiling of Cetuximab and Bevacizumab Treatment of Colorectal Tumours Reveals Perturbations in Metabolic and Hypoxic Response Pathways." Oncotarget 2015.
MLA引文Greening, David W., et al. "Molecular Profiling of Cetuximab and Bevacizumab Treatment of Colorectal Tumours Reveals Perturbations in Metabolic and Hypoxic Response Pathways." Oncotarget 2015.
警告：這些引文格式不一定是100％准確.